The in vitro experiments using recombinant Gas6 and a decoy-receptor of AXL showed that activation of Gas6-AXL signaling axis leads to the inhibition of apoptosis and exacerbation of AKT-dependent survival and invasion of gastric cancer cells (45). Here, AXL is linked to gastric cancer.